We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
Medica 2024
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Magnetic Nanoparticles Kill Tumors with Localized Heat

By LabMedica International staff writers
Posted on 25 Aug 2010
Magnetic nanoparticles coated with tumor specific antibodies have been used to detect tumors by thermographic imaging and destroy them by localized heating without damaging surrounding normal tissues.

Investigators at Tel Aviv University (Israel) conducted experiments using an in vitro tissue model, an inductive heating system, and an infrared camera. The thermal images, recorded by the infrared camera, were analyzed using an algorithm that was developed as part of the work.

Results published in the July 8, 2010, online edition of the journal Nanomedicine showed that small tumor phantoms (diameter of 0.5 mm) that were embedded under the surface of the tissue phantom (up to 14 mm below the surface) could be detected and located.

By coating the nanoparticles with antibodies directed at specific tumors, it was possible to administer them through the blood with subsequent concentration at the site of the tumor.

"Once the nanoparticles bind to the tumor, we excite them with an external magnetic field, and they begin to heat very specifically and locally,” explained senior author Dr. Israel Gannot, professor of biomedical engineering at Tel Aviv University. "The magnetic field is manipulated to create a targeted rise in temperature, and it is this directed heat elevation which kills the tumors.”

The U.S. Food and Drugs Administration (FDA)-approved nanoparticles are readily excreted from the body and they cause little or no damage to normal tissues.

Related Links:
Tel Aviv University



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Human Immunodeficiency Virus Assay
RealLine HIV Quantitative Kit
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries